Results for:(12 found)
Sep 19, 2013 10:59AM on Top StocksBy TheStreet Staff

Iclusig is not any more toxic than its competing leukemia drugs and its sales potential remains strong.

Aug 26, 2013 11:09AM on Top StocksBy Benzinga

Expect to see more mergers and acquisitions activity focused on cancer drugs.

Jul 31, 2013 10:55AM on Top StocksBy TheStreet Staff

The company must navigate several challenges in order for its leukemia drug Iclusig to become a blockbuster.

May 1, 2013 1:25PM on Top StocksBy StreetAuthority

With so many lives at stake, this billion-dollar industry has plenty of room to grow as companies compete to eliminate some of the most deadly strains.

Apr 26, 2013 11:52AM on InvestingBy Aimee Picchi

Nearly half of working-age Americans are avoiding doctors or skipping medications because of the spiraling expense.

Feb 8, 2013 12:43PM on Top StocksBy MSN Money Partner

Riverbed is downgraded at 2 firms, and Activision Blizzard is upgraded to 'outperform.'

Nov 9, 2012 12:33PM on Top StocksBy MSN Money Partner

Groupon is downgraded to 'equal weight,' while Isis Pharmaceuticals is upgraded to 'outperform.'

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More